Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Verleden (Leuven, Belgium), L. De Saedeleer (Leuven, Belgium), A. Van Herck (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), G. Verleden (Leuven, Belgium), R. Vos (Leuven, Belgium), W. Wuyts (Leuven, Belgium). Incidence of MUC5B minor allele in end-stage lung disease and implications for transplantation. 1734

Member's Comments

No comment yet.

Related content which might interest you: Effect of the type of end-stage lung disease on postoperative evolution of lung transplantation patients Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Caring for end-stage lung disease and lung transplantation Source: Annual Congress 2013 –PG20 Cystic fibrosis: an update of the basic defects and clinical problems in CF children and adults Year: 2013 Caring for end-stage disease and lung transplantation Source: International Congress 2018 – PG18 Cystic fibrosis: management in adult patients Year: 2018 Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD) Source: International Congress 2018 – Rare lung diseases Year: 2018 Osteoporosis in end-stage lung disease Source: Eur Respir Mon; 2009: 45: 62–78 Year: 2009 Chronic lung allograft disease: prevalence and FEV1 decline in a Brazilian lung transplant cohort. Source: International Congress 2017 – Lung transplant outcomes Year: 2017 Rapid decline in lung disease other than COPD: when should lung transplantation be considered? Source: Annual Congress 2007 - Rapid decline in lung function and its consequences Year: 2007 Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 The peculiarities of etiological verification of pulmonary TB in patients with chronic renal disease in the terminal stage before and after kidney transplantation Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 The effect of smoking in end-stage liver disease patients Source: Annual Congress 2010 - Distortions of the respiratory system in the lung function Year: 2010 CF lung disease and lung transplantation Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine Year: 2017 CF lung disease and lung transplantation Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019 Year: 2019 CF lung disease and lung transplantation Source: ERS Course 2018 - Summer school of paediatric respiratory medicine Year: 2018 Lumacaftor-Ivacaftor combination therapy in Phe508del homozygous CF patients with end-stage lung disease – preliminary results Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Monogenic gene variants in lung transplant recipients with usual interstitial pneumonia Source: ERJ Open Res, 8 (1) 00583-2021; 10.1183/23120541.00583-2021 Year: 2022 Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation Source: Annual Congress 2012 - Novel approaches to lung transplantation Year: 2012 Senotherapies for chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020 Poor patient adherence may contribute to increased skin cancer risk in heart and lung transplant recipients Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008